![Ofer Gonen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ofer Gonen
Directeur Général chez
MEDIWOUND LTD.
Fortune : 317 223 $ au 31/05/2026
Profil
Ofer Gonen currently works at MediWound Ltd., as Chief Executive Officer from 2022, CLAL Application Center Ltd., as Chairman, Biomedical Instruments Divison of Lionheart Tech, Inc., as Managing Director, CureTech Ltd., as Director from 2013, Clal Life Sciences (CLS) LP, as Director, BioCancell Therapeutics, Inc., as Director, Campus Bio Management Ltd., as Director from 2008, Avraham Pharmaceuticals Ltd., as Director, Campus Bio LLP, as Director, Center Ltd., as Director, and Gamida Cell, Inc., as Director.
Mr. Gonen also formerly worked at Clal Biotechnology Industries Ltd. (Venture Capital), as Chief Executive Officer from 2003 to 2022, Clal Biotechnology Industries Ltd., as Chief Executive Officer from 2017 to 2022, Polyheal Ltd., as Chairman from 2010 to 2014, eXIthera Pharmaceuticals, Inc., as Director, CLS Holdings Plc, as Director, Univo Pharmaceuticals Ltd., as Director, Gamida Cell Ltd., as Independent Director from 2015 to 2022, Andromeda Biotech Ltd., as Director from 2007 to 2014, Thrombotech Ltd., as Director, Braintact Ltd., as Director, Anchiano Therapeutics Ltd., as Director from 2015 to 2020, Cadent Ltd., as Director, Elicio Therapeutics, Inc. (United States), as Independent Director from 2021 to 2022, ColBar LifeScience Ltd., as Director, Cactus Acquisition Corp.
1 Ltd., as Director in 2024, Bank of Israel, as Governor, ARTE Venture Group Ltd., as Partner from 2003 to 2015, Biomedical Investments, as General Manager from 2007 to 2014, and Anatomy Medical Technology Fund, as Managing Partner.
Mr. Gonen received his graduate degree in 1998 from Tel-Aviv University and undergraduate degree in 1994 from The Hebrew University of Jerusalem.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MEDIWOUND LTD. 0,21 % | 18/03/2026 | 22 137 ( 0,21 % ) | 317 223 $ | 31/05/2026 |
Postes actifs de Ofer Gonen
| Sociétés | Poste | Début |
|---|---|---|
| MEDIWOUND LTD. | Directeur Général | 30/06/2022 |
Gamida Cell, Inc.
 Gamida Cell, Inc. BiotechnologyHealth Technology Develops cellular and immune therapeutics | Directeur/Membre du Conseil | - |
Campus Bio Management Ltd.
 Campus Bio Management Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development of biopharmaceuticals and medical devices | Directeur/Membre du Conseil | 13/04/2008 |
BioCancell Therapeutics, Inc.
 BioCancell Therapeutics, Inc. BiotechnologyHealth Technology Is a biopharmaceuticals company | Directeur/Membre du Conseil | - |
Center Ltd. | Directeur/Membre du Conseil | - |
CLAL Application Center Ltd. | Président | - |
Campus Bio LLP | Directeur/Membre du Conseil | - |
Avraham Pharmaceuticals Ltd.
 Avraham Pharmaceuticals Ltd. BiotechnologyHealth Technology Develops pharmaceutical products for prevention and treatment of neurodegenerative disorders | Directeur/Membre du Conseil | - |
Clal Life Sciences (CLS) LP
 Clal Life Sciences (CLS) LP Investment ManagersFinance Venture Capital Fund | Directeur/Membre du Conseil | - |
| ░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Anciens postes connus de Ofer Gonen
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░ ░░░░░░░░░░░ ░░░░░ ░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Ofer Gonen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
54
Relations au 1er degré
32
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 32 |
|---|---|
Anchiano Therapeutics Ltd.
 Anchiano Therapeutics Ltd. BiotechnologyHealth Technology Provides biopharmaceutical services | Health Technology |
Elicio Therapeutics, Inc. (United States)
 Elicio Therapeutics, Inc. (United States) BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel immunotherapies for treatment of cancer and other diseases | Health Technology |
eXIthera Pharmaceuticals, Inc.
 eXIthera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and manufactures stroke prevention & antithrombosis drugs | Health Technology |
CLS Holdings Plc
 CLS Holdings Plc Real Estate DevelopmentFinance Operates as a commercial property investment company | Finance |
Clal Biotechnology Industries Ltd.
 Clal Biotechnology Industries Ltd. Financial ConglomeratesFinance Provides investment and support services for life science research companies | Finance |
Biomedical Instruments Divison of Lionheart Tech, Inc.
 Biomedical Instruments Divison of Lionheart Tech, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops, markets, and manufactures quality assurance instrumentation, software and systems, and clinical training tools for hospital bioengineering departments | Electronic Technology |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Univo Pharmaceuticals Ltd.
 Univo Pharmaceuticals Ltd. Agricultural Commodities/MillingProcess Industries Engages in growing, manufacturing, processing, marketing and distribution of products medical cannabis | Process Industries |
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ColBar LifeScience Ltd.
 ColBar LifeScience Ltd. Medical SpecialtiesHealth Technology Develops technology for tissue regeneration and tissue engineering | Health Technology |
Bank of Israel
 Bank of Israel General GovernmentGovernment Central bank | Government |
Gamida Cell Ltd.
 Gamida Cell Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases | Health Technology |
Polyheal Ltd.
 Polyheal Ltd. Pharmaceuticals: MajorHealth Technology Provides wound healing products | Health Technology |
MediWound Ltd.
 MediWound Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops, manufactures and commercializes bio-therapeutic solutions for tissue repair and regeneration | Health Technology |
CureTech Ltd.
 CureTech Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Andromeda Biotech Ltd.
 Andromeda Biotech Ltd. Pharmaceuticals: MajorHealth Technology Develops treatment for autoimmune diabetes | Health Technology |
Clal Life Sciences (CLS) LP
Clal Life Sciences (CLS) LP Investment ManagersFinance Venture Capital Fund | Finance |
ARTE Venture Group Ltd.
 ARTE Venture Group Ltd. Investment ManagersFinance Acts as an alternative investment manager | Finance |
Biomedical Investments
 Biomedical Investments Investment ManagersFinance Biomedical Investments invests in companies based in Israel. The fund invests in health technology and medical specialities. It provides financing for early stage capital requirements. | Finance |
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology Is a biopharmaceuticals company | Health Technology |
Thrombotech Ltd.
 Thrombotech Ltd. Medical SpecialtiesHealth Technology Develops drugs that prevent and treat acute thromboembolic events | Health Technology |
Braintact Ltd.
 Braintact Ltd. Pharmaceuticals: MajorHealth Technology Develops neurodegenerative disorder drugs | Health Technology |
Clal Biotechnology Industries Ltd. (Venture Capital)
 Clal Biotechnology Industries Ltd. (Venture Capital) Investment ManagersFinance Clal Biotechnology Industries invests in companies located in Israel. The firm focuses on biotechnology and medical technology. It provides financing for seed and early stage capital requirements. | Finance |
Cadent Ltd.
 Cadent Ltd. Medical SpecialtiesHealth Technology Develops and distributes 3-D digital orthodontic and dental solutions | Health Technology |
Campus Bio Management Ltd.
Campus Bio Management Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development of biopharmaceuticals and medical devices | Health Technology |
Avraham Pharmaceuticals Ltd.
Avraham Pharmaceuticals Ltd. BiotechnologyHealth Technology Develops pharmaceutical products for prevention and treatment of neurodegenerative disorders | Health Technology |
Campus Bio LLP | |
CLAL Application Center Ltd. | |
Center Ltd. | |
Anatomy Medical Technology Fund
 Anatomy Medical Technology Fund Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Gamida Cell, Inc.
Gamida Cell, Inc. BiotechnologyHealth Technology Develops cellular and immune therapeutics | Health Technology |
Cactus Acquisition Corp. 1 Ltd.
 Cactus Acquisition Corp. 1 Ltd. Financial ConglomeratesFinance Operates as a blank check company | Finance |
